The Medical and Scientific Affairs team at Shatterproof is responsible for supporting the organization's mission by ensuring the highest standards in treatment quality and strategy. This team collaborates with scientific experts and payer partnerships to advance evidence-based practices, promote innovative research, and ultimately improve the lives of individuals affected by addiction. Their work involves providing insights that shape treatment protocols and health policies, fostering a comprehensive approach to addiction care.
Ajani Nimmagadda
Scientific Board Member
Alisa Bahl
Scientific Board Member
Douglas Nemecek
Scientific Board Member
Lexi Van Besien
Scientific Board Member
Martin H. Rosenzweig
Scientific Board Member
Mike Mesewicz
Vice President, Payer Partners...
Shannon Biello, MPH
Vice President, Treatment Qual...
Thomas McLellan
Scientific Board Member
View all